US Patent 7595293 Stable pharmaceutical compositions

Patent 7595293 was granted and assigned to Novo Nordisk on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75952930

Patent Inventor Names

Tina Bjeldskov Pedersen0

Claude Bonde0

Dorthe Kot Engelund0

Date of Patent

September 29, 2009

Patent Application Number

112444970

Date Filed

October 3, 2005

Patent Citations Received

‌

US Patent 11752198 GLP-1 compositions and uses thereof

Patent Primary Examiner

‌

Karen Cochrane Carlson

Patent abstract

Pharmaceutical composition for parenteral administration comprising a glucagon-like peptide and human serum albumin or a variant thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7595293 Stable pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API